Year archive

Pharmadrug Inc. — 2022 filings

All 27 regulatory filings released by Pharmadrug Inc. (PHRX) in 2022, sourced directly from the official regulator.

27 Filings

2022 Period

2022 filings (27)

Filing	Released	Lang
News release - English.pdf Capital/Financing Update	2022-10-04	English
News release - English.pdf Regulatory Filings	2022-08-25	English
Material change report - English.pdf Regulatory Filings	2022-08-04	English
Material change report - English.pdf Regulatory Filings	2022-08-04	English
News release - English.pdf Capital/Financing Update	2022-08-03	English
News release - English.pdf Capital/Financing Update	2022-08-02	English
News release - English.pdf Regulatory Filings	2022-06-16	English
Audited annual financial statements – English.pdf Audit Report / Information	2022-05-03	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-05-03	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-05-03	English
Annual MD&A - English.pdf Management Reports	2022-05-03	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2022-05-03	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2022-05-03	English
News release - English.pdf Regulatory Filings	2022-05-03	English
News release - English.pdf Regulatory Filings	2022-04-19	English
News release - English.pdf Regulatory Filings	2022-04-07	English
Material document(s).pdf Regulatory Filings	2022-04-05	English
Material document(s).pdf Regulatory Filings	2022-04-05	English
Material document(s).pdf Regulatory Filings	2022-04-05	English
Material document(s).pdf Regulatory Filings	2022-04-05	English
Material document(s).pdf Regulatory Filings	2022-04-05	English
Material document(s).pdf Regulatory Filings	2022-04-05	English
News release - English.pdf Regulatory Filings	2022-02-23	English
News release - English.pdf Regulatory Filings	2022-01-26	English
News release - English.pdf Regulatory Filings	2022-01-24	English
News release - English.pdf Investor Presentation	2022-01-24	English
News release - English.pdf Board/Management Information	2022-01-13	English